US Investigates GSK Following Chinese Bribery Claims
A GSK representative confirmed in a statement the U.S. Department of Justice is looking into the bribery accusations against the company in China. U.S. authorities have been probing GSK's business practices overseas for several years.
"Since the investigation in China began, we have pro actively reached out to relevant...
To view the full article, register now.